42 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
4
Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.
Northern Illinois University
12
Synthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors.
Nanjing University
31
Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells.
Johns Hopkins University School of Medicine
47
QSAR study of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2 using LS-SVM and GRNN based on principal components.
Kermanshah University of Medical Sciences
30
Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors.
Universit£T Heidelberg
6
A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products.
University of California Santa Cruz
11
Investigation of novel fumagillin analogues as angiogenesis inhibitors.
Gilead Sciences
16
Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors.
Nanjing University
15
Innovative design and potential applications of covalent strategy in drug discovery.
Sichuan University
6
Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
The Johns Hopkins University School of Medicine
5
Novel Antimicrobial 8-Hydroxyquinoline-Based Agents: Current Development, Structure-Activity Relationships, and Perspectives.
Universidade Federal Do Rio Grande Do Sul
21
Design and synthesis of beta-amino-alpha-hydroxy amide derivatives as inhibitors of MetAP2 and HUVEC growth.
Celera
99
3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.
Abbott Laboratories
4
Peptidyl hydroxamic acids as methionine aminopeptidase inhibitors.
The Ohio State University
3
Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
Johns Hopkins University School of Medicine
35
Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight 'molecular budget'.
Glaxosmithkline
36
Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors.
Merck Healthcare
20
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.
Eberhard Karls University T£Bingen
13
Research progress in the biological activities of 3,4,5-trimethoxycinnamic acid (TMCA) derivatives.
Northwest University
7
The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects.
Colorado Mesa University
86
Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein
The Governing Council of The University of Toronto
19
Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases
Ono Pharmaceutical
28
Heterocyclic GSK-3 allosteric modulators
Consejo Superior de Investigaciones Cientificas (CSIC)
43
Substituted tetrahydrocarbazole and carbazole carboxamide compounds
Bristol Myers Squibb
23
Fused pyrimidine compound, and preparation method, intermediate, composition, and uses thereof
Shanghai Yingli Pharmaceutical
465
5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof
Genentech
6
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
Emory University
4
Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor.
Leicester Royal Infirmary
14
Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum.
University of Texas At Dallas
11
Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine a.
University of British Columbia
3
Conformation-assisted inhibition of protein-tyrosine phosphatase-1B elicits inhibitor selectivity over T-cell protein-tyrosine phosphatase.
Merck Frosst Center For Therapeutic Research
15
A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues.
Banyu Tsukuba Research Institute